Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors
Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic rev...
Saved in:
| Published in: | PLoS medicine Vol. 19; no. 5; p. e1004011 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Public Library of Science
26.05.2022
Public Library of Science (PLoS) |
| Subjects: | |
| ISSN: | 1549-1676, 1549-1277, 1549-1676 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail.
We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination.
Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. |
|---|---|
| AbstractList | Background Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail. Methods and findings We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients’ symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies’ heterogeneity in viral load assessment and sample origination. Conclusions Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. Background Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail. Methods and findings We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values [greater than or equal to]25 and [greater than or equal to]30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination. Conclusions Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. Background Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail. Methods and findings We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients’ symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies’ heterogeneity in viral load assessment and sample origination. Conclusions Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail. We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values [greater than or equal to]25 and [greater than or equal to]30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination. Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail.BACKGROUNDComprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail.We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination.METHODS AND FINDINGSWe registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination.Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed.CONCLUSIONSAg-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. BackgroundComprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail.Methods and findingsWe registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination.ConclusionsAg-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail. We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination. Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed. Lukas Brümmer and co-workers report an updated systematic review and meta-analysis on the accuracy of antigen-based rapid diagnostic tests for SARS-CoV-2 infection. |
| Audience | Academic |
| Author | Katzenschlager, Stephan Ongarello, Stefano Brümmer, Lukas E. Sacks, Jilian A. Macé, Aurélien Grilli, Maurizio Erkosar, Berra Pollock, Nira R. Bota, Marc Carmona, Sergio Gaeddert, Mary Schmitz, Stephani Weigand, Markus A. Denkinger, Claudia M. McGrath, Sean Erdmann, Christian Larmann, Jan |
| AuthorAffiliation | 6 Agaplesion Bethesda Hospital, Hamburg, Germany 8 Department of Laboratory Medicine, Boston Children’s Hospital, Boston, Massachusetts, United States of America 10 German Center for Infection Research (DZIF), partner site Heidelberg University Hospital, Heidelberg, Germany 4 Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands 5 FH Muenster University of Applied Sciences, Muenster, Germany 1 Division of Infectious Disease and Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany 9 FIND, Geneva, Switzerland 3 Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America 7 Library, University Medical Center Mannheim, Mannheim, Germany 2 Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany PLOS Medicine Editorial Board, UNITED STATES |
| AuthorAffiliation_xml | – name: 2 Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany – name: 8 Department of Laboratory Medicine, Boston Children’s Hospital, Boston, Massachusetts, United States of America – name: 10 German Center for Infection Research (DZIF), partner site Heidelberg University Hospital, Heidelberg, Germany – name: 9 FIND, Geneva, Switzerland – name: 1 Division of Infectious Disease and Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany – name: PLOS Medicine Editorial Board, UNITED STATES – name: 7 Library, University Medical Center Mannheim, Mannheim, Germany – name: 4 Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands – name: 6 Agaplesion Bethesda Hospital, Hamburg, Germany – name: 3 Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America – name: 5 FH Muenster University of Applied Sciences, Muenster, Germany |
| Author_xml | – sequence: 1 givenname: Lukas E. orcidid: 0000-0002-8812-7975 surname: Brümmer fullname: Brümmer, Lukas E. – sequence: 2 givenname: Stephan orcidid: 0000-0003-4977-7999 surname: Katzenschlager fullname: Katzenschlager, Stephan – sequence: 3 givenname: Sean orcidid: 0000-0002-7281-3516 surname: McGrath fullname: McGrath, Sean – sequence: 4 givenname: Stephani orcidid: 0000-0003-1188-2750 surname: Schmitz fullname: Schmitz, Stephani – sequence: 5 givenname: Mary orcidid: 0000-0002-6713-3495 surname: Gaeddert fullname: Gaeddert, Mary – sequence: 6 givenname: Christian orcidid: 0000-0003-0159-128X surname: Erdmann fullname: Erdmann, Christian – sequence: 7 givenname: Marc orcidid: 0000-0003-0265-8642 surname: Bota fullname: Bota, Marc – sequence: 8 givenname: Maurizio surname: Grilli fullname: Grilli, Maurizio – sequence: 9 givenname: Jan orcidid: 0000-0003-3365-4572 surname: Larmann fullname: Larmann, Jan – sequence: 10 givenname: Markus A. surname: Weigand fullname: Weigand, Markus A. – sequence: 11 givenname: Nira R. orcidid: 0000-0002-6396-2915 surname: Pollock fullname: Pollock, Nira R. – sequence: 12 givenname: Aurélien orcidid: 0000-0002-3282-1650 surname: Macé fullname: Macé, Aurélien – sequence: 13 givenname: Berra orcidid: 0000-0003-1152-6772 surname: Erkosar fullname: Erkosar, Berra – sequence: 14 givenname: Sergio orcidid: 0000-0002-6792-4748 surname: Carmona fullname: Carmona, Sergio – sequence: 15 givenname: Jilian A. surname: Sacks fullname: Sacks, Jilian A. – sequence: 16 givenname: Stefano orcidid: 0000-0002-0032-0691 surname: Ongarello fullname: Ongarello, Stefano – sequence: 17 givenname: Claudia M. orcidid: 0000-0002-7216-7067 surname: Denkinger fullname: Denkinger, Claudia M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35617375$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVk9tqGzEQhpeS0hzaNyitoFDai3WlPUi7uSiY0EMgNBC3uRWzWmkts5YcSZvUfaW-ZOXYCXEwpWUvVoy--WdGM3OY7BlrZJK8JHhEckY-zOzgDPSjxVy2I4JxgQl5khyQsqhTQhnde3DeTw69n2Gc1bjGz5L9vKSE5aw8SH6PhRgciCWyCjlY6BYtrDYhtSoV4CQCE3QnTdqAly1qNXTG-qCFR8o6NBlfTNITe5lmx2hs0LBoIUTML32Qc4gYcvJay5so06K5DJBCzHnptUc3OkzXJic7J73X1qDb21_adEgb1Q_SiNVZgQjW-efJUwW9ly82_6Pkx-dP30--pmfnX05PxmepYLQIaUEhU3VTUaBZDVWdS9IUsi5zLBuiqFAtZqoVuC6LhjEMFWUip2VV45aJBrf5UfJ6rbvoreebd_Y8oyzqlwXBkThdE62FGV84PQe35BY0vzVY13FwsfpecirqLPYma1kmClVKYCpGwg3JBKY0J1Hr4yba0MRWCmmCg35LdPvG6Cnv7DWvScVwnUWBdxsBZ68G6QOfay9k34ORdrjNm2S0wmUe0TeP0N3VbagOYgGxETbGFStRPma4rKusqFZUuoOKoyJjknFUlY7mLX60g49fK-da7HR4v-UQmSB_hg4G7_np5OI_2G__zp5fbrNvH7BTCX2YetsPIQ6r3wZfPeziffvuNi0CxRoQznrvpLpHCOarhb5rBV8tNN8sdHQ7fuQmdIBV-Ph6uv-78x8HV1FJ |
| CitedBy_id | crossref_primary_10_1515_cclm_2023_0087 crossref_primary_10_1016_j_diagmicrobio_2024_116677 crossref_primary_10_3389_ijph_2023_1605452 crossref_primary_10_1186_s12985_024_02371_5 crossref_primary_10_3390_diagnostics12112829 crossref_primary_10_1111_1753_6405_13285 crossref_primary_10_1128_spectrum_02525_23 crossref_primary_10_1007_s00430_023_00774_9 crossref_primary_10_1016_j_cmi_2022_10_028 crossref_primary_10_5694_mja2_52151 crossref_primary_10_1093_haschl_qxaf151 crossref_primary_10_1136_bmjopen_2024_084555 crossref_primary_10_1016_j_talanta_2025_127815 crossref_primary_10_1089_heq_2023_0020 crossref_primary_10_1016_j_cmi_2025_07_009 crossref_primary_10_1371_journal_pone_0303560 crossref_primary_10_1186_s12889_024_17930_2 crossref_primary_10_1371_journal_pone_0316467 crossref_primary_10_1002_mco2_726 crossref_primary_10_1016_j_cmi_2023_12_009 crossref_primary_10_1128_cmr_00072_23 crossref_primary_10_1002_rmv_2569 crossref_primary_10_7759_cureus_87120 crossref_primary_10_1038_s41598_023_46461_w crossref_primary_10_1016_j_diagmicrobio_2024_116309 crossref_primary_10_1007_s15010_023_02135_3 crossref_primary_10_1038_s41598_023_48892_x crossref_primary_10_1136_bmjopen_2022_066776 crossref_primary_10_1186_s12879_024_09408_8 crossref_primary_10_1039_D3SD00246B crossref_primary_10_1016_j_heliyon_2023_e19492 crossref_primary_10_1515_cclm_2022_1058 crossref_primary_10_1093_ofid_ofae433 crossref_primary_10_1016_j_ajic_2022_11_002 crossref_primary_10_1371_journal_pone_0303254 crossref_primary_10_1016_j_jcvp_2023_100140 crossref_primary_10_1016_j_cmi_2023_05_009 crossref_primary_10_1007_s15010_025_02600_1 crossref_primary_10_1016_j_cmi_2025_03_006 crossref_primary_10_1093_labmed_lmac089 crossref_primary_10_1128_spectrum_05044_22 crossref_primary_10_11124_JBIES_23_00291 crossref_primary_10_1007_s00216_025_05916_x crossref_primary_10_1007_s10389_025_02599_7 crossref_primary_10_1016_j_ebiom_2024_105394 crossref_primary_10_1038_s41598_024_57817_1 crossref_primary_10_1016_j_cmi_2023_04_019 |
| Cites_doi | 10.1186/1471-2288-14-70 10.1016/j.jcv.2021.104781 10.1007/s40121-021-00413-x 10.1016/j.jcv.2021.104941 10.1371/journal.pone.0253321 10.1183/13993003.04430-2020 10.3390/jcm10102099 10.1128/JCM.00977-20 10.1128/JCM.03282-20 10.4103/ijo.IJO_430_21 10.1371/journal.pone.0247606 10.1002/jmv.27108 10.3390/microorganisms9040798 10.1016/j.jcv.2021.104785 10.1136/bmj.n71 10.3390/microorganisms9081700 10.2471/BLT.16.170860 10.1016/j.jviromet.2021.114165 10.1172/JCI138759 10.1186/s12985-020-01452-5 10.1007/s00430-020-00698-8 10.3855/jidc.13925 10.7717/peerj.10801 10.3389/fmed.2020.00225 10.1128/JCM.02338-20 10.1080/1354750X.2021.1876769 10.1002/jmv.26830 10.1183/13993003.03961-2020 10.1016/j.jhin.2021.01.018 10.1002/jmv.27033 10.5578/mb.20219815 10.1002/jmv.26983 10.1016/j.jviromet.2021.114201 10.1128/JCM.01107-21 10.1093/cid/ciaa1382 10.3390/jcm10112404 10.1016/j.jcv.2021.104930 10.1016/j.eclinm.2021.100954 10.1371/journal.pmed.1003735 10.1016/j.jcv.2021.104874 10.3390/jcm10132774 10.1128/JCM.00083-21 10.3390/v13040684 10.1016/j.jcv.2020.104455 10.3390/pathogens10010038 10.1128/JCM.00896-21 10.1016/j.ijid.2020.05.098 10.1016/j.jcv.2021.104961 10.3390/jcm10020328 10.1016/j.jcv.2021.104838 10.1016/j.diagmicrobio.2021.115514 10.1016/j.infpip.2021.100142 10.7326/0003-4819-151-4-200908180-00135 10.1016/S2666-5247(21)00143-9 10.1371/journal.pbio.3001333 10.1016/j.jpeds.2021.01.027 10.1016/j.jviromet.2020.114024 10.15585/mmwr.mm7019a3 10.1016/j.tmaid.2020.101942 10.1128/Spectrum.00342-21 10.1016/j.jiac.2020.11.016 10.1128/JCM.00569-21 10.1371/journal.pone.0248921 10.1093/infdis/jiaa802 10.1016/j.ajog.2021.01.002 10.1016/j.ijid.2021.05.063 10.1016/j.eclinm.2021.100924 10.1016/j.eclinm.2020.100677 10.1056/NEJMc2102507 10.1371/journal.pone.0247918 10.1016/j.cmi.2020.09.030 10.3390/v13050818 10.7326/M20-5926 10.3201/eid2705.204688 10.3390/microorganisms9010058 10.3390/jcm10020265 10.1016/j.lanwpc.2021.100115 10.3343/alm.2022.42.1.100 10.1038/s41598-021-94055-1 10.3390/v14040654 10.3343/alm.2021.41.6.588 10.1371/journal.pone.0250886 10.1371/journal.pmed.1001935 10.3390/ijerph18126310 10.3390/healthcare9070868 10.18637/jss.v036.i03 10.1128/JCM.00991-21 10.1136/bmj.n1676 10.1542/peds.2021-050832 10.1016/j.jfma.2021.07.011 10.1016/j.ijid.2020.10.073 10.1016/j.ijid.2021.07.010 10.7326/0003-4819-149-12-200812160-00008 10.1016/j.jcv.2021.104854 10.1016/j.diagmicrobio.2021.115434 10.1093/ofid/ofab243 10.1128/JCM.00260-21 10.3390/ijerph18137037 10.1007/s10096-021-04202-9 10.1371/journal.pbio.3001216 10.1016/j.ijid.2021.07.043 10.1136/bmj.n1637 10.1016/j.jcv.2020.104713 10.1371/journal.pone.0256352 10.1093/jtm/taab085 10.1038/s41598-021-90026-8 10.1016/j.jhin.2021.03.021 10.1002/jmv.27089 10.1016/j.ijid.2021.04.072 10.1016/j.nmni.2021.100899 10.1016/j.jcv.2020.104659 10.1371/journal.pone.0257817 10.7326/0003-4819-155-8-201110180-00009 10.3390/diagnostics11060995 10.1016/j.ijid.2021.03.051 10.3390/diagnostics11071211 10.1016/S1473-3099(21)00249-8 10.1186/s12879-021-06524-7 10.3126/kumj.v18i2.32942 10.3389/fped.2021.647274 10.1016/j.jcvp.2021.100013 10.1016/j.jcv.2021.104846 10.1016/j.jcv.2020.104654 10.3201/eid2710.210080 10.1016/j.ijid.2021.04.087 10.1017/ice.2021.281 10.1016/j.jcv.2021.104878 10.1016/j.jiac.2021.07.006 10.1515/dx-2020-0154 10.1016/j.jiac.2021.02.029 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2022 Public Library of Science 2022 Brümmer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Brümmer et al 2022 Brümmer et al |
| Copyright_xml | – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Brümmer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Brümmer et al 2022 Brümmer et al |
| DBID | AAYXX CITATION NPM IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA CZK |
| DOI | 10.1371/journal.pmed.1004011 |
| DatabaseName | CrossRef PubMed Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ PLoS Medicine |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| DocumentTitleAlternate | Accuracy of point-of-care Ag-RDTs for SARS-CoV-2 |
| EISSN | 1549-1676 |
| ExternalDocumentID | 2677645410 oai_doaj_org_article_6c920402d72c4f5ea7f8900b12c06631 PMC9187092 A705982480 35617375 10_1371_journal_pmed_1004011 |
| Genre | Journal Article |
| GeographicLocations | Germany |
| GeographicLocations_xml | – name: Germany |
| GrantInformation_xml | – fundername: ; – fundername: ; grantid: DGE1745303 – fundername: ; grantid: 300341-102 – fundername: ; grantid: 2019-32-FIND MDR |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACCTH ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AFFHD AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAIFH BAWUL BBTPI BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M ALIPV NPM 3V. 7TK 7XB 8FK AZQEC COVID DWQXO K9. PKEHL PQEST PQUKI 7X8 PUEGO 5PM - AAPBV ABPTK ACDSR ADACO BBAFP BCGST CZK ICW M~E PRINS |
| ID | FETCH-LOGICAL-c764t-46a2f9b86a629a893e1b4e9530eb1f6cfd07fdc0954b770a867c365890d7cb0d3 |
| IEDL.DBID | FPL |
| ISICitedReferencesCount | 57 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000944355600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1549-1676 1549-1277 |
| IngestDate | Sun Jul 03 04:10:32 EDT 2022 Fri Oct 03 12:52:38 EDT 2025 Tue Nov 04 02:00:16 EST 2025 Thu Oct 02 10:15:08 EDT 2025 Sat Nov 29 14:42:07 EST 2025 Tue Nov 11 10:12:27 EST 2025 Sat Nov 29 11:31:32 EST 2025 Tue Nov 04 17:16:18 EST 2025 Thu Nov 13 15:46:44 EST 2025 Thu Nov 13 14:53:47 EST 2025 Thu Nov 13 14:37:31 EST 2025 Thu May 22 21:20:27 EDT 2025 Mon Jul 21 05:53:04 EDT 2025 Sat Nov 29 06:34:23 EST 2025 Tue Nov 18 20:38:44 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c764t-46a2f9b86a629a893e1b4e9530eb1f6cfd07fdc0954b770a867c365890d7cb0d3 |
| Notes | new_version ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 I have read the journal’s policy and the authors of this manuscript have the following competing interests: CMD is a member of the Editorial Board of PLOS Medicine. CMD also declares a payment from Roche Diagnostics that she accepted as German law requires a manufacturer to pay for the use of data for regulatory purposes. Data was generated as part of an independent evaluation by CMD and team. AM, BE, SC, JAS and SO are employees of FIND, the global alliance for diagnostics. |
| ORCID | 0000-0002-0032-0691 0000-0003-1188-2750 0000-0003-3365-4572 0000-0002-7216-7067 0000-0002-3282-1650 0000-0003-0265-8642 0000-0003-4977-7999 0000-0002-8812-7975 0000-0002-6713-3495 0000-0002-6396-2915 0000-0003-1152-6772 0000-0002-7281-3516 0000-0003-0159-128X 0000-0002-6792-4748 |
| OpenAccessLink | http://dx.doi.org/10.1371/journal.pmed.1004011 |
| PMID | 35617375 |
| PQID | 2677645410 |
| PQPubID | 1436338 |
| ParticipantIDs | plos_journals_2677645410 doaj_primary_oai_doaj_org_article_6c920402d72c4f5ea7f8900b12c06631 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9187092 proquest_miscellaneous_2671268053 proquest_journals_2677645410 gale_infotracmisc_A705982480 gale_infotracgeneralonefile_A705982480 gale_infotracacademiconefile_A705982480 gale_incontextgauss_ISR_A705982480 gale_incontextgauss_ISN_A705982480 gale_incontextgauss_IOV_A705982480 gale_healthsolutions_A705982480 pubmed_primary_35617375 crossref_primary_10_1371_journal_pmed_1004011 crossref_citationtrail_10_1371_journal_pmed_1004011 |
| PublicationCentury | 2000 |
| PublicationDate | 20220526 |
| PublicationDateYYYYMMDD | 2022-05-26 |
| PublicationDate_xml | – month: 5 year: 2022 text: 20220526 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PLoS medicine |
| PublicationTitleAlternate | PLoS Med |
| PublicationYear | 2022 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | I Baccani (pmed.1004011.ref030) 2021; 101 Y Seynaeve (pmed.1004011.ref160) 2021; 10 A Audigé (pmed.1004011.ref227) 2021; 9 C Lunca (pmed.1004011.ref120) 2021 pmed.1004011.ref198 pmed.1004011.ref199 P Mertens (pmed.1004011.ref124) 2020; 7 Prisma Group (pmed.1004011.ref011) 2009; 151 A Osterman (pmed.1004011.ref136) 2021; 210 B Kenyeres (pmed.1004011.ref094) 2021; 293 A Šterbenc (pmed.1004011.ref167) 2021 pmed.1004011.ref196 pmed.1004011.ref197 pmed.1004011.ref194 pmed.1004011.ref195 JK Frediani (pmed.1004011.ref071) 2021; 11 C Jung (pmed.1004011.ref089) 2021; 9 A Lindner (pmed.1004011.ref116) 2020; 57 M Möckel (pmed.1004011.ref126) 2021; 26 D Kim (pmed.1004011.ref097) 2021; 13 RD Smith (pmed.1004011.ref166) 2021 N Van der Moeren (pmed.1004011.ref185) 2021; 16 I Thirion-Romero (pmed.1004011.ref178) 2021 M Linares (pmed.1004011.ref115) 2020; 133 S Dierks (pmed.1004011.ref056) 2021; 10 LJ Krüger (pmed.1004011.ref105) 2021; 16 MJ Page (pmed.1004011.ref214) 2021; 372 LE Brümmer (pmed.1004011.ref004) 2021; 18 MD Fernández (pmed.1004011.ref066) 2021 R Chiu (pmed.1004011.ref050) 2021; 9 DEPRESsion Screening Data Collaboration (pmed.1004011.ref015) 2020 AK Lindner (pmed.1004011.ref118) 2021; 141 M Shah (pmed.1004011.ref161) 2021; 73 BS Karon (pmed.1004011.ref093) 2021 EB Hodcroft (pmed.1004011.ref016) 2021 H Suzuki (pmed.1004011.ref171) 2021 MT Ngo Nsoga (pmed.1004011.ref129) 2021; 16 V Schildgen (pmed.1004011.ref155) 2020; 10 J Agarwal (pmed.1004011.ref023) 2021; 15 Z Abusrewil (pmed.1004011.ref022) 2021 J Nordgren (pmed.1004011.ref131) 2021; 140 SC Tsai (pmed.1004011.ref183) 2021; 120 T Toptan (pmed.1004011.ref180) 2020; 135 A Lindner (pmed.1004011.ref216) 2021 L Bornemann (pmed.1004011.ref037) 2021; 140 Z Dankova (pmed.1004011.ref053) 2021; 18 B Osmanodja (pmed.1004011.ref135) 2021; 10 M García-Fiñana (pmed.1004011.ref072) 2021; 374 E Albert (pmed.1004011.ref027) 2020; 27 S Carbonell-Sahuquillo (pmed.1004011.ref043) 2021 CM Bachman (pmed.1004011.ref031) 2021; 16 R Arnaout (pmed.1004011.ref230) 2021; 73 W. Viechtbauer (pmed.1004011.ref018) 2010; 36 A Orsi (pmed.1004011.ref134) 2021; 295 JE Kirby (pmed.1004011.ref232) 2021 N Pollock (pmed.1004011.ref146) 2021; 59 M Pena (pmed.1004011.ref140) 2021; 107 Y Takeuchi (pmed.1004011.ref174) 2021; 11 G Turcato (pmed.1004011.ref184) 2020; 82 S Jegerlehner (pmed.1004011.ref087) 2021; 109 KK Kumar (pmed.1004011.ref108) 2021; 69 V Herrera (pmed.1004011.ref078) 2020 A Nalumansi (pmed.1004011.ref128) 2020; 104 E Shidlovskaya (pmed.1004011.ref164) 2021 P Merino-Amador (pmed.1004011.ref122) 2021; 143 J-M Schwob (pmed.1004011.ref157) 2020; 17 J Stohr (pmed.1004011.ref168) 2021 T Weitzel (pmed.1004011.ref189) 2021; 21 S Fourati (pmed.1004011.ref070) 2021; 142 A Pekosz (pmed.1004011.ref139) 2020 S Muhi (pmed.1004011.ref127) 2021; 9 Y Akashi (pmed.1004011.ref025) 2021 A Gupta (pmed.1004011.ref075) 2020; 153 A Fernandez-Montero (pmed.1004011.ref067) 2021; 37 G Caruana (pmed.1004011.ref045) 2021; 42 BF Escrivá (pmed.1004011.ref061) 2021; 143 LT Allan-Blitz (pmed.1004011.ref029) 2021; 59 J Favresse (pmed.1004011.ref063) 2021; 10 A Abdul-Mumin (pmed.1004011.ref020) 2021 M Ifko (pmed.1004011.ref083) 2021; 9 E Kolwijck (pmed.1004011.ref102) 2021; 3 LJ Krüger (pmed.1004011.ref106) 2021 Z Kipritci (pmed.1004011.ref099) 2021; 55 LJ Krüger (pmed.1004011.ref104) 2020 T. Peto (pmed.1004011.ref143) 2021; 36 S Young (pmed.1004011.ref193) 2020; 59 J Deerain (pmed.1004011.ref217) 2021 G Marais (pmed.1004011.ref225) 2021 G Caruana (pmed.1004011.ref044) 2021; 9 Y Takeda (pmed.1004011.ref172) 2020 LE Brümmer (pmed.1004011.ref005) 2021; 01 World Health Organization (pmed.1004011.ref001) 2021 MRS Bouassa (pmed.1004011.ref038) 2021; 106 B Bruzzone (pmed.1004011.ref040) 2021; 107 MJ Mina (pmed.1004011.ref231) 2020; 383 V Agulló (pmed.1004011.ref024) 2020; 82 NG Cassuto (pmed.1004011.ref046) 2021 N Kohmer (pmed.1004011.ref101) 2021; 10 P Merino-Amador (pmed.1004011.ref123) 2020; 27 OL Akingba (pmed.1004011.ref026) 2021; 1 J Schrom (pmed.1004011.ref226) 2022 J Lee (pmed.1004011.ref112) 2021; 41 Y Wang (pmed.1004011.ref009) 2020; 130 World Health Organization (pmed.1004011.ref017) 2022 JL Gomez Marti (pmed.1004011.ref073) 2021 R Kanaujia (pmed.1004011.ref091) 2021 G Leixner (pmed.1004011.ref113) 2021; 108 C Holzner (pmed.1004011.ref079) 2021; 93 K Christensen (pmed.1004011.ref051) 2021 P Thakur (pmed.1004011.ref176) 2021 G Sberna (pmed.1004011.ref154) 2021; 27 C Callahan (pmed.1004011.ref215) 2021; 59 B Adamson (pmed.1004011.ref224) 2022 K Modjarrad (pmed.1004011.ref229) 2016; 13 A Scohy (pmed.1004011.ref158) 2020; 129 N Pollock (pmed.1004011.ref012) 2020; 59 PF Whiting (pmed.1004011.ref014) 2011; 155 R Thell (pmed.1004011.ref177) 2021 PK Drain (pmed.1004011.ref058) 2021; 10 MA Qahtani (pmed.1004011.ref150) 2021 E Parada-Ricart (pmed.1004011.ref138) 2020; 39 C Wertenauer (pmed.1004011.ref190) 2021 M Ciotti (pmed.1004011.ref052) 2021; 93 V Caramello (pmed.1004011.ref042) 2021; 83 N Yin (pmed.1004011.ref191) 2021; 8 M Di Domenico (pmed.1004011.ref055) 2021; 18 F Pérez-García (pmed.1004011.ref141) 2021; 137 GL Salvagno (pmed.1004011.ref153) 2021; 8 BC Young (pmed.1004011.ref192) 2021; 82 H Houston (pmed.1004011.ref082) 2021; 110 V Cento (pmed.1004011.ref047) 2021; 13 L Blairon (pmed.1004011.ref036) 2021; 93 T Ferté (pmed.1004011.ref068) 2021; 141 L Porte (pmed.1004011.ref149) 2020; 99 S Lambert-Niclot (pmed.1004011.ref111) 2020; 58 C Johnson (pmed.1004011.ref088) 2021 E Van Honacker (pmed.1004011.ref186) 2021; 114 H Gremmels (pmed.1004011.ref074) 2020; 31 O Bulilete (pmed.1004011.ref041) 2021; 82 HW Kim (pmed.1004011.ref098) 2022; 42 N Shaikh (pmed.1004011.ref162) 2021; 148 Y Kurihara (pmed.1004011.ref109) 2021; 27 S Villaverde (pmed.1004011.ref187) 2021; 232 P Filgueiras (pmed.1004011.ref069) 2021 J Ferguson (pmed.1004011.ref065) 2021; 19 SN Onsongo (pmed.1004011.ref133) 2021 pmed.1004011.ref211 pmed.1004011.ref212 pmed.1004011.ref210 NC Okoye (pmed.1004011.ref132) 2021; 59 pmed.1004011.ref213 F Fenollar (pmed.1004011.ref064) 2020; 59 C Chaimayo (pmed.1004011.ref049) 2020; 17 W Stokes (pmed.1004011.ref169) 2021; 40 Michelena Pd (pmed.1004011.ref220) 2022 I Eleftheriou (pmed.1004011.ref060) 2021 M Homza (pmed.1004011.ref081) 2021; 53 pmed.1004011.ref208 pmed.1004011.ref209 A Berger (pmed.1004011.ref034) 2020; 16 pmed.1004011.ref206 L Porte (pmed.1004011.ref148) 2020; 9 pmed.1004011.ref207 World Health Organization (pmed.1004011.ref003) 2021 AE Jääskeläinen (pmed.1004011.ref085) 2021; 137 pmed.1004011.ref200 B Baro (pmed.1004011.ref032) 2021; 82 M Kahn (pmed.1004011.ref090) 2021; 21 pmed.1004011.ref201 I Torres (pmed.1004011.ref182) 2020; 27 pmed.1004011.ref204 World Health Organization (pmed.1004011.ref223) 2022 pmed.1004011.ref205 pmed.1004011.ref202 pmed.1004011.ref203 SM Kissler (pmed.1004011.ref221) 2021; 385 T Weitzel (pmed.1004011.ref188) 2020; 39 J Dinnes (pmed.1004011.ref002) 2021; 3 Z Iglὁi (pmed.1004011.ref084) 2020; 27 AE James (pmed.1004011.ref086) 2021 M Homza (pmed.1004011.ref080) 2021; 13 E Terpos (pmed.1004011.ref175) 2021; 11 FM Liotti (pmed.1004011.ref119) 2020; 27 F Perez-Garcia (pmed.1004011.ref142) 2021; 93 G Menchinelli (pmed.1004011.ref121) 2021; 11 M Bekliz (pmed.1004011.ref218) 2021 A Brihn (pmed.1004011.ref039) 2021; 70 A Krüttgen (pmed.1004011.ref107) 2020; 288 SM Kissler (pmed.1004011.ref008) 2021; 19 A Abdulrahman (pmed.1004011.ref021) 2020 DT Harris (pmed.1004011.ref077) 2021; 9 S Pickering (pmed.1004011.ref144) 2021; 2 A Alemany (pmed.1004011.ref028) 2020; 82 G Bianco (pmed.1004011.ref035) 2021; 139 AK Lindner (pmed.1004011.ref117) 2021; 57 A Strömer (pmed.1004011.ref170) 2020; 9 S Kernéis (pmed.1004011.ref095) 2021 A Rottenstreich (pmed.1004011.ref152) 2021; 224 M Nehme (pmed.1004011.ref007) 2021; 174 ET Beck (pmed.1004011.ref033) 2020; 59 World Health Organization (pmed.1004011.ref013) 2021 A Kilic (pmed.1004011.ref096) 2021; 59 F Cerutti (pmed.1004011.ref048) 2020; 132 M Ristić (pmed.1004011.ref151) 2021; 16 E Schuit (pmed.1004011.ref156) 2021; 374 P Drevinek (pmed.1004011.ref059) 2020 P Halfon (pmed.1004011.ref076) 2021; 16 JA Hay (pmed.1004011.ref222) 2022 M Korenkov (pmed.1004011.ref103) 2021; 59 C Dye (pmed.1004011.ref228) 2016; 94 A Osterman (pmed.1004011.ref137) 2021 NR Pollock (pmed.1004011.ref147) 2021; 8 A L’Huillier (pmed.1004011.ref110) 2021; 59 WA van Enst (pmed.1004011.ref019) 2014; 14 G Pilarowski (pmed.1004011.ref145) 2020; 223 M Micocci (pmed.1004011.ref125) 2021 T Seitz (pmed.1004011.ref159) 2021; 93 C Leli (pmed.1004011.ref114) 2021; 110 J-L Bayart (pmed.1004011.ref219) 2022; 14 O Nikolai (pmed.1004011.ref130) 2021 JGM Koeleman (pmed.1004011.ref100) 2021 I Torres (pmed.1004011.ref181) 2021; 82 JLV Shaw (pmed.1004011.ref163) 2021; 101 Y Takeuchi (pmed.1004011.ref173) 2021; 27 pmed.1004011.ref006 MM Leeflang (pmed.1004011.ref010) 2008; 149 M Domínguez Fernández (pmed.1004011.ref057) 2021 B Shrestha (pmed.1004011.ref165) 2020; 18 SC Tinker (pmed.1004011.ref179) 2021; 27 KS Faíco-Filho (pmed.1004011.ref062) 2021 P Kannian (pmed.1004011.ref092) 2021; 00 C Del Vecchio (pmed.1004011.ref054) 2021 |
| References_xml | – year: 2021 ident: pmed.1004011.ref088 article-title: Evaluation of the Panbio SARS-CoV-2 rapid antigen detection test in the Bahamas. publication-title: medRxiv – ident: pmed.1004011.ref203 – volume: 14 start-page: 70 year: 2014 ident: pmed.1004011.ref019 article-title: Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study. publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-70 – volume: 137 start-page: 104781 year: 2021 ident: pmed.1004011.ref141 article-title: Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection. publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104781 – volume: 10 start-page: 753 issue: 2 year: 2021 ident: pmed.1004011.ref058 article-title: A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study. publication-title: Infect Dis Ther. doi: 10.1007/s40121-021-00413-x – volume: 143 start-page: 104941 year: 2021 ident: pmed.1004011.ref061 article-title: The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain. publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104941 – volume: 16 start-page: e0253321 issue: 6 year: 2021 ident: pmed.1004011.ref129 article-title: Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2. publication-title: PLoS ONE doi: 10.1371/journal.pone.0253321 – ident: pmed.1004011.ref198 – volume: 57 start-page: 2004430 issue: 5 year: 2020 ident: pmed.1004011.ref116 article-title: Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab publication-title: Eur Respir J doi: 10.1183/13993003.04430-2020 – start-page: S0213 year: 2021 ident: pmed.1004011.ref057 article-title: Experience with Panbio rapid antigens test device for the detection of SARS-CoV-2 in nursing homes. publication-title: Enferm Infecc Microbiol Clin. – volume: 10 issue: 10 year: 2021 ident: pmed.1004011.ref135 article-title: Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs. publication-title: Journal of. Clin Med doi: 10.3390/jcm10102099 – volume: 82 start-page: 276 year: 2021 ident: pmed.1004011.ref192 article-title: Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital. publication-title: J Inf Secur – volume: 83 start-page: 237 year: 2021 ident: pmed.1004011.ref042 article-title: Are antigenic tests useful for detecting SARS-CoV-2 infections in patients accessing to emergency departments? Results from a North-West Italy Hospital. publication-title: J Inf Secur. – volume: 3 start-page: CD013705 year: 2021 ident: pmed.1004011.ref002 article-title: Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. publication-title: Cochrane Database Syst Rev – volume: 73 start-page: S54 year: 2021 ident: pmed.1004011.ref161 article-title: Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020 publication-title: Clin Infect Dis – year: 2021 ident: pmed.1004011.ref062 article-title: Evaluation of the Panbio COVID-19 Ag Rapid Test at an Emergency Room in a Hospital in São Paulo, Brazil. publication-title: medRxiv – volume: 58 start-page: e00977 issue: 8 year: 2020 ident: pmed.1004011.ref111 article-title: Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs publication-title: J Clin Microbiol doi: 10.1128/JCM.00977-20 – volume: 82 start-page: 391 year: 2021 ident: pmed.1004011.ref041 article-title: Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care. publication-title: J Inf Secur – volume: 59 start-page: e03282 issue: 4 year: 2021 ident: pmed.1004011.ref132 article-title: Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting publication-title: J Clin Microbiol doi: 10.1128/JCM.03282-20 – volume: 59 start-page: e03077 year: 2020 ident: pmed.1004011.ref012 article-title: Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay publication-title: J Clin Microbiol – volume: 69 start-page: 1560 issue: 6 year: 2021 ident: pmed.1004011.ref108 article-title: Pre-Operative SARS CoV-2 Rapid Antigen Test and Reverse Transcription Polymerase Chain Reaction: A conundrum in surgical decision making. publication-title: Indian J Ophthalmol. doi: 10.4103/ijo.IJO_430_21 – volume: 16 start-page: e0247606 issue: 2 year: 2021 ident: pmed.1004011.ref151 article-title: Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia. publication-title: PLoS ONE. doi: 10.1371/journal.pone.0247606 – start-page: 1 year: 2021 ident: pmed.1004011.ref106 article-title: Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx: An antigen-detecting point-of-care device for SARS-CoV-2. publication-title: Infection – volume: 93 start-page: 5783 year: 2021 ident: pmed.1004011.ref036 article-title: Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance publication-title: J Med Virol doi: 10.1002/jmv.27108 – volume: 9 start-page: 798 issue: 4 year: 2021 ident: pmed.1004011.ref044 article-title: ImplemeNting SARS-CoV-2 Rapid antigen testing in the Emergency wArd of a Swiss univErsity hospital: the INCREASE study. publication-title: Microorganisms doi: 10.3390/microorganisms9040798 – volume: 137 start-page: 104785 year: 2021 ident: pmed.1004011.ref085 article-title: Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104785 – ident: pmed.1004011.ref209 – volume: 372 start-page: n71 year: 2021 ident: pmed.1004011.ref214 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: Br Med J doi: 10.1136/bmj.n71 – volume: 9 start-page: 1700 issue: 8 year: 2021 ident: pmed.1004011.ref227 article-title: Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs. publication-title: Microorganisms doi: 10.3390/microorganisms9081700 – volume: 94 start-page: 158 issue: 3 year: 2016 ident: pmed.1004011.ref228 article-title: Data sharing in public health emergencies: a call to researchers publication-title: Bull World Health Organ doi: 10.2471/BLT.16.170860 – volume: 293 start-page: 114165 year: 2021 ident: pmed.1004011.ref094 article-title: Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2021.114165 – volume: 9 start-page: 539 issue: 5 year: 2021 ident: pmed.1004011.ref077 article-title: SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus. publication-title: Biomedicine – year: 2021 ident: pmed.1004011.ref025 article-title: Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2. publication-title: medRxiv – ident: pmed.1004011.ref208 – volume: 130 start-page: 5235 issue: 10 year: 2020 ident: pmed.1004011.ref009 article-title: Kinetics of viral load and antibody response in relation to COVID-19 severity. publication-title: J Clin Investig doi: 10.1172/JCI138759 – volume: 17 start-page: 177 issue: 1 year: 2020 ident: pmed.1004011.ref049 article-title: Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. publication-title: Virol J doi: 10.1186/s12985-020-01452-5 – volume: 210 start-page: 65 issue: 1 year: 2021 ident: pmed.1004011.ref136 article-title: Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting publication-title: Med Microbiol Immunol doi: 10.1007/s00430-020-00698-8 – volume: 15 start-page: 904 issue: 7 year: 2021 ident: pmed.1004011.ref023 article-title: “David vs. Goliath”: A simple antigen detection test with potential to change diagnostic strategy for SARS-CoV-2. publication-title: J Infect Dev Ctries doi: 10.3855/jidc.13925 – volume: 9 start-page: e10801 year: 2020 ident: pmed.1004011.ref148 article-title: Evaluation of two fluorescence immunoassays for the rapid detection of SARS-CoV-2 antigen—new tool to detect infective COVID-19 patients. publication-title: PeerJ doi: 10.7717/peerj.10801 – start-page: 1 year: 2021 ident: pmed.1004011.ref130 article-title: Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter? publication-title: Infect Dis Ther. – volume: 7 start-page: 225 year: 2020 ident: pmed.1004011.ref124 article-title: Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context. publication-title: Front Med. doi: 10.3389/fmed.2020.00225 – volume: 59 issue: 1 year: 2020 ident: pmed.1004011.ref193 article-title: Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test publication-title: J Clin Microbiol doi: 10.1128/JCM.02338-20 – volume: 13 issue: 5 year: 2021 ident: pmed.1004011.ref097 article-title: Development and Clinical Evaluation of an Immunochromatography-Based Rapid Antigen Test (GenBody COVAG025) for COVID-19 Diagnosis. publication-title: Viruses-Basel. – ident: pmed.1004011.ref199 – volume: 26 start-page: 213 issue: 3 year: 2021 ident: pmed.1004011.ref126 article-title: SARS-CoV-2 Antigen Rapid Immunoassay for Diagnosis of COVID-19 in the Emergency Department. publication-title: Biomarkers doi: 10.1080/1354750X.2021.1876769 – volume: 59 start-page: e02589 year: 2020 ident: pmed.1004011.ref064 article-title: Evaluation of the Panbio Covid-19 rapid antigen detection test device for the screening of patients with Covid-19 publication-title: J Clin Microbiol – year: 2022 ident: pmed.1004011.ref220 article-title: Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant. publication-title: J Inf Secur. – start-page: 1 year: 2021 ident: pmed.1004011.ref046 article-title: Evaluation of a SARS-CoV-2 antigen-detecting rapid diagnostic test as a self-test: diagnostic performance and usability publication-title: J Med Virol – ident: pmed.1004011.ref194 – year: 2021 ident: pmed.1004011.ref051 article-title: Clinical evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for point-of-care (POC) System. publication-title: medRxiv – year: 2020 ident: pmed.1004011.ref078 article-title: Testing of Healthcare Workers Exposed to COVID19 with Rapid Antigen Detection. publication-title: medRxiv – year: 2021 ident: pmed.1004011.ref125 article-title: Point of Care Testing using rapid automated Antigen Testing for SARS-COV-2 in Care Homes–an exploratory safety, usability and diagnostic agreement evaluation. publication-title: medRxiv – volume: 82 start-page: 186 issue: 5 year: 2020 ident: pmed.1004011.ref028 article-title: Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test. publication-title: J Inf Secur. – volume: 27 start-page: 472 issue: 3 year: 2020 ident: pmed.1004011.ref027 article-title: Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. publication-title: Clin Microbiol Infect – volume: 93 start-page: 2988 year: 2021 ident: pmed.1004011.ref052 article-title: Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection publication-title: J Med Virol doi: 10.1002/jmv.26830 – volume: 57 issue: 4 year: 2021 ident: pmed.1004011.ref117 article-title: Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab publication-title: Eur Respir J doi: 10.1183/13993003.03961-2020 – volume: 110 start-page: 203 year: 2021 ident: pmed.1004011.ref082 article-title: Diagnostic accuracy and utility of SARS-CoV-2 antigen lateral flow assays in medical admissions with possible COVID-19. publication-title: J Hosp Infect doi: 10.1016/j.jhin.2021.01.018 – volume: 93 start-page: 5323 year: 2021 ident: pmed.1004011.ref079 article-title: SARS-CoV-2 rapid antigen test: Fast-safe or dangerous? An analysis in the emergency department of an university hospital publication-title: J Med Virol doi: 10.1002/jmv.27033 – year: 2021 ident: pmed.1004011.ref003 publication-title: Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance – year: 2021 ident: pmed.1004011.ref066 article-title: Usefulness of the LumiraDx SARS-COV-2 antigen test in nursing home. publication-title: Enferm Infecc Microbiol Clin. – year: 2021 ident: pmed.1004011.ref069 article-title: COVID-19 Rapid Antigen Test at hospital admission associated to the knowledge of individual risk factors allow overcoming the difficulty of managing suspected patients in hospitals COVID-19 Rapid Antigen Test facilitates the management of suspected patients on hospital admission. publication-title: medRxiv – volume: 55 start-page: 461 issue: 3 year: 2021 ident: pmed.1004011.ref099 article-title: Evaluation of a Visually-Read Rapid Antigen Test Kit (SGA V-Chek) for Detection of SARS-CoV-2 Virus. publication-title: Mikrobiyol Bul. doi: 10.5578/mb.20219815 – volume: 93 start-page: 4161 year: 2021 ident: pmed.1004011.ref159 article-title: Evaluation of rapid antigen tests based on saliva for the detection of SARS-CoV-2 publication-title: J Med Virol doi: 10.1002/jmv.26983 – volume: 295 start-page: 114201 year: 2021 ident: pmed.1004011.ref134 article-title: On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-COV-2 diagnostic publication-title: J Virol Methods doi: 10.1016/j.jviromet.2021.114201 – year: 2021 ident: pmed.1004011.ref178 article-title: Evaluation of a rapid antigen test for SARS-CoV-2 in symptomatic patients and their contacts: a multicenter study. publication-title: medRxiv – volume: 59 start-page: e0110721 issue: 10 year: 2021 ident: pmed.1004011.ref029 article-title: A Real-World Comparison of SARS-CoV-2 Rapid Antigen vs. Polymerase Chain Reaction Testing in Florida publication-title: J Clin Microbiol doi: 10.1128/JCM.01107-21 – volume: 73 start-page: e3042 issue: 9 year: 2021 ident: pmed.1004011.ref230 article-title: The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa1382 – volume: 10 start-page: 2404 issue: 11 year: 2021 ident: pmed.1004011.ref056 article-title: Diagnosing SARS-CoV-2 with Antigen Testing, Transcription-Mediated Amplification and Real-Time PCR. publication-title: J Clin Med. doi: 10.3390/jcm10112404 – volume: 142 start-page: 104930 year: 2021 ident: pmed.1004011.ref070 article-title: Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use. publication-title: J Clin Virol. doi: 10.1016/j.jcv.2021.104930 – volume: 37 start-page: 100954 year: 2021 ident: pmed.1004011.ref067 article-title: Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values. publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2021.100954 – volume: 18 start-page: e1003735 issue: 8 year: 2021 ident: pmed.1004011.ref004 article-title: Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. publication-title: PLoS Med. doi: 10.1371/journal.pmed.1003735 – volume: 82 start-page: E14 year: 2020 ident: pmed.1004011.ref184 article-title: Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report. publication-title: J Inf Secur – ident: pmed.1004011.ref205 – volume: 141 start-page: 104874 year: 2021 ident: pmed.1004011.ref118 article-title: Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test. publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104874 – volume: 27 start-page: 758 issue: 5 year: 2020 ident: pmed.1004011.ref123 article-title: Multicenter evaluation of the Panbio COVID-19 Rapid Antigen-Detection Test for the diagnosis of SARS-CoV-2 infection publication-title: Clin Microbiol Infect – volume: 10 start-page: 2774 issue: 13 year: 2021 ident: pmed.1004011.ref160 article-title: Evaluation of Two Rapid Antigenic Tests for the Detection of SARS-CoV-2 in Nasopharyngeal Swabs. publication-title: J Clin Med. doi: 10.3390/jcm10132774 – volume: 59 start-page: e00083 issue: 5 year: 2021 ident: pmed.1004011.ref146 article-title: Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-throughput Drive-through Community Testing Site in Massachusetts publication-title: J Clin Microbiol doi: 10.1128/JCM.00083-21 – start-page: 1 year: 2021 ident: pmed.1004011.ref100 article-title: Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection publication-title: Eur J Clin Microbiol Infect Dis – volume: 13 issue: 4 year: 2021 ident: pmed.1004011.ref080 article-title: Five Antigen Tests for SARS-CoV-2: Virus Viability Matters. publication-title: Viruses doi: 10.3390/v13040684 – year: 2020 ident: pmed.1004011.ref021 article-title: Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients. publication-title: medRxiv – volume: 129 start-page: 104455 year: 2020 ident: pmed.1004011.ref158 article-title: Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104455 – year: 2021 ident: pmed.1004011.ref218 article-title: Analytical sensitivity of seven SARS-CoV-2 antigen-detecting rapid tests for Omicron variant. publication-title: medRxiv – ident: pmed.1004011.ref006 – volume: 82 start-page: e11 issue: 5 year: 2021 ident: pmed.1004011.ref181 article-title: Point-of-care evaluation of a rapid antigen test (CLINITEST) Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals. publication-title: J Inf Secur. – volume: 10 start-page: 38 issue: 1 year: 2020 ident: pmed.1004011.ref155 article-title: Limits and opportunities of SARS-CoV-2 antigen rapid tests–an experience based perspective. publication-title: Pathogens doi: 10.3390/pathogens10010038 – volume: 59 start-page: e0089621 issue: 9 year: 2021 ident: pmed.1004011.ref103 article-title: Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals publication-title: J Clin Microbiol doi: 10.1128/JCM.00896-21 – volume: 99 start-page: 328 year: 2020 ident: pmed.1004011.ref149 article-title: Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.05.098 – year: 2021 ident: pmed.1004011.ref176 article-title: Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings. publication-title: Lab Med. – year: 2020 ident: pmed.1004011.ref104 article-title: Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. publication-title: medRxiv – volume: 143 start-page: 104961 year: 2021 ident: pmed.1004011.ref122 article-title: Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study. publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104961 – volume: 10 issue: 2 year: 2021 ident: pmed.1004011.ref101 article-title: The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro publication-title: Journal of. Clin Med doi: 10.3390/jcm10020328 – year: 2021 ident: pmed.1004011.ref001 publication-title: Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities – volume: 139 start-page: 104838 year: 2021 ident: pmed.1004011.ref035 article-title: Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection. publication-title: J Clin Virol. doi: 10.1016/j.jcv.2021.104838 – volume: 101 start-page: 115514 issue: 4 year: 2021 ident: pmed.1004011.ref163 article-title: Evaluation of the Abbott Panbio COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2021.115514 – ident: pmed.1004011.ref204 – volume: 3 start-page: 100142 issue: 2 year: 2021 ident: pmed.1004011.ref102 article-title: Validation and implementation of the Panbio COVID-19 Ag rapid test for the diagnosis of SARS-CoV-2 infection in symptomatic hospital healthcare workers. publication-title: Infect Prev Pract doi: 10.1016/j.infpip.2021.100142 – volume: 151 start-page: 264 issue: 4 year: 2009 ident: pmed.1004011.ref011 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: Ann Intern Med doi: 10.7326/0003-4819-151-4-200908180-00135 – volume: 8 start-page: 380 year: 2021 ident: pmed.1004011.ref191 article-title: SARS-CoV-2 Diagnostic Tests: Algorithm and Field Evaluation From the Near Patient Testing to the Automated Diagnostic Platform. publication-title: Front Med. – volume: 2 start-page: E461 issue: 9 year: 2021 ident: pmed.1004011.ref144 article-title: Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study publication-title: Lancet Microbe doi: 10.1016/S2666-5247(21)00143-9 – start-page: 1 year: 2021 ident: pmed.1004011.ref022 article-title: Time scale performance of rapid antigen testing for SARS-COV-2: evaluation of ten rapid antigen assays publication-title: J Med Virol – volume: 19 start-page: e3001333 issue: 7 year: 2021 ident: pmed.1004011.ref008 article-title: Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies publication-title: PLoS Biol doi: 10.1371/journal.pbio.3001333 – ident: pmed.1004011.ref195 – start-page: 1 year: 2021 ident: pmed.1004011.ref086 article-title: Performance of the BinaxNOW COVID-19 Antigen Card test relative to the SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction assay among symptomatic and asymptomatic healthcare employees. publication-title: Infect Control Hosp Epidemiol. – year: 2021 ident: pmed.1004011.ref016 publication-title: CoVariants: SARS-CoV-2 Mutations and Variants of Interest – ident: pmed.1004011.ref210 – volume: 01 year: 2021 ident: pmed.1004011.ref005 article-title: The accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. publication-title: medRxiv – volume: 232 start-page: P287 year: 2021 ident: pmed.1004011.ref187 article-title: Diagnostic Accuracy of the Panbio SARS-CoV-2 Antigen Rapid Test Compared with Rt-Pcr Testing of Nasopharyngeal Samples in the Pediatric Population publication-title: J Pediatr doi: 10.1016/j.jpeds.2021.01.027 – volume: 288 start-page: 114024 year: 2020 ident: pmed.1004011.ref107 article-title: Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit publication-title: J Virol Methods doi: 10.1016/j.jviromet.2020.114024 – volume: 70 start-page: 702 issue: 19 year: 2021 ident: pmed.1004011.ref039 article-title: Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting—Los Angeles County, California, June-August 2020. publication-title: Morb Mortal Wkly Rep. doi: 10.15585/mmwr.mm7019a3 – year: 2022 ident: pmed.1004011.ref223 publication-title: Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing – volume: 39 start-page: 101942 year: 2020 ident: pmed.1004011.ref188 article-title: Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium. publication-title: Travel Med Infect Dis doi: 10.1016/j.tmaid.2020.101942 – start-page: hvab138 year: 2021 ident: pmed.1004011.ref093 article-title: Analytical sensitivity and specificity of four point of care rapid antigen diagnostic tests for SARS-CoV-2 using real-time quantitative PCR, quantitative droplet digital PCR, and a mass spectrometric antigen assay as comparator methods publication-title: Clin Chem – year: 2021 ident: pmed.1004011.ref060 article-title: Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children publication-title: J Med Virol – volume: 383 issue: 22 year: 2020 ident: pmed.1004011.ref231 article-title: Rethinking Covid-19 Test Sensitivity—A Strategy for Containment publication-title: N Engl J Med – volume: 9 start-page: e0034221 issue: 1 year: 2021 ident: pmed.1004011.ref050 article-title: Evaluation of the INDICAID COVID-19 Rapid Antigen Test in symptomatic populations and asymptomatic community testing. publication-title: Microbiol Spectr. doi: 10.1128/Spectrum.00342-21 – volume: 27 start-page: 384 issue: 2 year: 2021 ident: pmed.1004011.ref154 article-title: Letter of concern re: "Immunochromatographic test for the detection of SARS-CoV-2 in saliva. publication-title: J Infect Chemother doi: 10.1016/j.jiac.2020.11.016 – volume: 59 start-page: e0056921 issue: 9 year: 2021 ident: pmed.1004011.ref215 article-title: Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2 publication-title: J Clin Microbiol doi: 10.1128/JCM.00569-21 – volume: 16 start-page: e0248921 issue: 3 year: 2020 ident: pmed.1004011.ref034 article-title: Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers. publication-title: PLoS ONE doi: 10.1371/journal.pone.0248921 – ident: pmed.1004011.ref206 – volume: 223 start-page: 1139 issue: 7 year: 2020 ident: pmed.1004011.ref145 article-title: Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco publication-title: J Infect Dis doi: 10.1093/infdis/jiaa802 – volume: 224 start-page: 539 issue: 5 year: 2021 ident: pmed.1004011.ref152 article-title: Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery. publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2021.01.002 – year: 2022 ident: pmed.1004011.ref222 article-title: Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant. publication-title: medRxiv – volume: 108 start-page: 353 year: 2021 ident: pmed.1004011.ref113 article-title: Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.05.063 – volume: 36 start-page: 100924 year: 2021 ident: pmed.1004011.ref143 article-title: COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing. publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2021.100924 – year: 2022 ident: pmed.1004011.ref226 article-title: Direct Comparison of SARS CoV-2 Nasal RT- PCR and Rapid Antigen Test (BinaxNOW(TM)) at a Community Testing Site During an Omicron Surge. publication-title: medRxiv – volume: 31 start-page: 100677 year: 2020 ident: pmed.1004011.ref074 article-title: Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. publication-title: EClinicalMedicine. doi: 10.1016/j.eclinm.2020.100677 – volume: 385 start-page: 2489 issue: 26 year: 2021 ident: pmed.1004011.ref221 article-title: Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons publication-title: N Engl J Med doi: 10.1056/NEJMc2102507 – year: 2020 ident: pmed.1004011.ref015 article-title: Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. publication-title: Stat Methods Med Res. – year: 2021 ident: pmed.1004011.ref164 article-title: The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2. publication-title: medRxiv – volume: 16 start-page: e0247918 issue: 5 year: 2021 ident: pmed.1004011.ref105 article-title: The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use. publication-title: PLoS ONE. doi: 10.1371/journal.pone.0247918 – volume: 27 start-page: 487 year: 2020 ident: pmed.1004011.ref119 article-title: Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.09.030 – year: 2021 ident: pmed.1004011.ref177 article-title: Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2. publication-title: medRxiv – year: 2021 ident: pmed.1004011.ref020 article-title: Field evaluation of specificity and sensitivity of a standard SARS-CoV-2 antigen rapid diagnostic test: A prospective study at a teaching hospital in Northern Ghana. publication-title: medRxiv – ident: pmed.1004011.ref212 – volume: 13 start-page: 818 issue: 5 year: 2021 ident: pmed.1004011.ref047 article-title: Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR? publication-title: Viruses-Basel. doi: 10.3390/v13050818 – start-page: ciaa1706 year: 2020 ident: pmed.1004011.ref139 article-title: Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture publication-title: Clin Infect Dis – volume: 174 start-page: 723 issue: 5 year: 2021 ident: pmed.1004011.ref007 article-title: COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings publication-title: Ann Intern Med doi: 10.7326/M20-5926 – volume: 27 start-page: 1323 issue: 5 year: 2020 ident: pmed.1004011.ref084 article-title: Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site publication-title: Emerg Infect Dis doi: 10.3201/eid2705.204688 – volume: 9 issue: 1 year: 2020 ident: pmed.1004011.ref170 article-title: Performance of a Point-of-Care Test for the Rapid Detection of SARS-CoV-2 Antigen. publication-title: Microorganisms doi: 10.3390/microorganisms9010058 – volume: 10 start-page: 265 issue: 2 year: 2021 ident: pmed.1004011.ref063 article-title: Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection. publication-title: J Clin Med. doi: 10.3390/jcm10020265 – volume: 9 start-page: 100115 year: 2021 ident: pmed.1004011.ref127 article-title: Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study publication-title: Lancet Reg Health West Pac doi: 10.1016/j.lanwpc.2021.100115 – year: 2021 ident: pmed.1004011.ref073 article-title: Differences in detected viral loads guide use of SARS-CoV-2 antigen-detection assays towards symptomatic college students and children. publication-title: medRxiv – volume: 42 start-page: 100 issue: 1 year: 2022 ident: pmed.1004011.ref098 article-title: Clinical Evaluation of the Rapid STANDARD Q COVID-19 Ag Test for the Screening of Severe Acute Respiratory Syndrome Coronavirus 2. publication-title: Ann Lab Med. doi: 10.3343/alm.2022.42.1.100 – volume: 11 start-page: 14604 issue: 1 year: 2021 ident: pmed.1004011.ref071 article-title: Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration. publication-title: Sci Rep doi: 10.1038/s41598-021-94055-1 – ident: pmed.1004011.ref196 – volume: 27 start-page: 636 issue: 4 year: 2020 ident: pmed.1004011.ref182 article-title: Real-life evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. publication-title: Clin Microbiol Infect – volume: 14 start-page: 654 issue: 4 year: 2022 ident: pmed.1004011.ref219 article-title: Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant. publication-title: Viruses doi: 10.3390/v14040654 – volume: 41 start-page: 588 issue: 6 year: 2021 ident: pmed.1004011.ref112 article-title: Clinical Performance of the Standard Q COVID-19 Rapid Antigen Test and Simulation of its Real-World Application in Korea. publication-title: Ann Lab Med. doi: 10.3343/alm.2021.41.6.588 – ident: pmed.1004011.ref211 – volume: 16 start-page: e0250886 issue: 5 year: 2021 ident: pmed.1004011.ref185 article-title: Evaluation of the test accuracy of a SARS-CoV-2 rapid antigen test in symptomatic community dwelling individuals in the Netherlands. publication-title: PLoS ONE. doi: 10.1371/journal.pone.0250886 – volume: 13 start-page: e1001935 issue: 1 year: 2016 ident: pmed.1004011.ref229 article-title: Developing Global Norms for Sharing Data and Results during Public Health Emergencies. publication-title: PLoS Med. doi: 10.1371/journal.pmed.1001935 – volume: 18 start-page: 6310 issue: 12 year: 2021 ident: pmed.1004011.ref055 article-title: Diagnostic Accuracy of a New Antigen Test for SARS-CoV-2 Detection. publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph18126310 – volume: 9 start-page: 868 issue: 7 year: 2021 ident: pmed.1004011.ref083 article-title: Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly. publication-title: Health doi: 10.3390/healthcare9070868 – volume: 36 start-page: 1 issue: 3 year: 2010 ident: pmed.1004011.ref018 article-title: Conducting Meta-Analyses in R with the metafor Package. publication-title: J Stat Softw. doi: 10.18637/jss.v036.i03 – year: 2022 ident: pmed.1004011.ref224 article-title: Discordant SARS-CoV-2 PCR and Rapid Antigen Test Results When Infectious: A December 2021 Occupational Case Series. publication-title: medRxiv – volume: 59 start-page: e00991 issue: 9 year: 2021 ident: pmed.1004011.ref110 article-title: Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting publication-title: J Clin Microbiol doi: 10.1128/JCM.00991-21 – ident: pmed.1004011.ref200 – start-page: 1 year: 2021 ident: pmed.1004011.ref043 article-title: Evaluation of a rapid antigen detection test (Panbio COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a Pediatric Emergency Department. publication-title: J Med Virol – volume: 00 start-page: 1 year: 2021 ident: pmed.1004011.ref092 article-title: SARS-CoV2 antigen in whole mouth fluid may be a reliable rapid detection tool publication-title: Oral Dis – volume: 374 start-page: n1676 year: 2021 ident: pmed.1004011.ref156 article-title: Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study publication-title: Br Med J doi: 10.1136/bmj.n1676 – volume: 148 start-page: e2021050832 issue: 3 year: 2021 ident: pmed.1004011.ref162 article-title: Performance of a Rapid SARS-CoV-2 Antigen Detection Assay in Symptomatic Children publication-title: Pediatrics doi: 10.1542/peds.2021-050832 – volume: 120 start-page: 2042 issue: 10 year: 2021 ident: pmed.1004011.ref183 article-title: Real world clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan publication-title: J Formos Med Assoc doi: 10.1016/j.jfma.2021.07.011 – volume: 104 start-page: 282 year: 2020 ident: pmed.1004011.ref128 article-title: Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.10.073 – volume: 109 start-page: 118 year: 2021 ident: pmed.1004011.ref087 article-title: Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.07.010 – volume: 149 start-page: 889 issue: 12 year: 2008 ident: pmed.1004011.ref010 article-title: Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy publication-title: Ann Intern Med doi: 10.7326/0003-4819-149-12-200812160-00008 – volume: 140 start-page: 104854 year: 2021 ident: pmed.1004011.ref037 article-title: Real-life evaluation of the Sofia SARS-CoV-2 antigen assay in a large tertiary care hospital. publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104854 – volume: 101 start-page: 115434 issue: 2 year: 2021 ident: pmed.1004011.ref030 article-title: Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2021.115434 – volume: 8 start-page: ofab243 issue: 7 year: 2021 ident: pmed.1004011.ref147 article-title: Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts. publication-title: Open Forum. Infect Dis Ther doi: 10.1093/ofid/ofab243 – year: 2021 ident: pmed.1004011.ref054 article-title: Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests. publication-title: medRxiv – volume: 59 issue: 5 year: 2021 ident: pmed.1004011.ref096 article-title: Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19 publication-title: J Clin Microbiol doi: 10.1128/JCM.00260-21 – year: 2022 ident: pmed.1004011.ref017 publication-title: Tracking SARS-CoV-2 variants – volume: 18 issue: 13 year: 2021 ident: pmed.1004011.ref053 article-title: Comparison of SARS-CoV-2 Detection by Rapid Antigen and by Three Commercial RT-qPCR Tests: A Study from Martin University Hospital in Slovakia. publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph18137037 – volume: 40 start-page: 1721 issue: 8 year: 2021 ident: pmed.1004011.ref169 article-title: Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-021-04202-9 – volume: 19 start-page: e3001216 issue: 4 year: 2021 ident: pmed.1004011.ref065 article-title: Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key publication-title: PLoS Biol doi: 10.1371/journal.pbio.3001216 – volume: 110 start-page: 135 year: 2021 ident: pmed.1004011.ref114 article-title: Performance of a SARS CoV-2 antigen rapid immunoassay in patients admitted to the Emergency Department publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.07.043 – year: 2021 ident: pmed.1004011.ref190 article-title: Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study. publication-title: medRxiv – volume: 374 start-page: n1637 year: 2021 ident: pmed.1004011.ref072 article-title: Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study publication-title: Br Med J doi: 10.1136/bmj.n1637 – ident: pmed.1004011.ref213 – volume: 82 start-page: 186 issue: 5 year: 2020 ident: pmed.1004011.ref024 article-title: Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs: A population-based point-of-care study. publication-title: J Inf Secur. – volume: 82 start-page: 269 issue: 6 year: 2021 ident: pmed.1004011.ref032 article-title: Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. publication-title: J Inf Secur – volume: 135 start-page: 104713 year: 2020 ident: pmed.1004011.ref180 article-title: Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread? publication-title: J Clin Virol. doi: 10.1016/j.jcv.2020.104713 – year: 2021 ident: pmed.1004011.ref091 article-title: Rapid antigen detection kit for the diagnosis of SARS-CoV-2—are we missing asymptomatic patients? publication-title: Indian J Med Microbiol – volume: 16 start-page: e0256352 issue: 8 year: 2021 ident: pmed.1004011.ref031 article-title: Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays. publication-title: PLoS ONE doi: 10.1371/journal.pone.0256352 – start-page: taab085 year: 2021 ident: pmed.1004011.ref150 article-title: SARS-CoV-2 rapid antigen testing for departing passengers at Vancouver international airport. publication-title: J Travel Med. doi: 10.1093/jtm/taab085 – volume: 17 start-page: 862 issue: 737 year: 2020 ident: pmed.1004011.ref157 article-title: Diagnostic du Covid-19 en milieu ambulatoire. publication-title: Rev Med Suisse. – volume: 11 start-page: 10519 issue: 1 year: 2021 ident: pmed.1004011.ref174 article-title: Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study. publication-title: Sci Rep doi: 10.1038/s41598-021-90026-8 – volume: 39 start-page: 357 year: 2020 ident: pmed.1004011.ref138 article-title: Usefulness of the antigen for diagnosing SARS-CoV-2 infection in patients with and without symptoms. publication-title: Enferm Infecc Microbiol Clin – year: 2021 ident: pmed.1004011.ref216 article-title: SARS-CoV-2 patient self-testing with an antigen-detecting rapid test: a head-to-head comparison with professional testing. publication-title: medRxiv – ident: pmed.1004011.ref202 – volume: 114 start-page: 144 year: 2021 ident: pmed.1004011.ref186 article-title: Comparison of five SARS-CoV-2 rapid antigen detection tests in a hospital setting and performance of one antigen assay in routine practice: a useful tool to guide isolation precautions? publication-title: J Hosp Infect. doi: 10.1016/j.jhin.2021.03.021 – ident: pmed.1004011.ref197 – year: 2021 ident: pmed.1004011.ref171 article-title: Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): a prospective observational study with 1,127 nasopharyngeal samples. publication-title: medRxiv – year: 2021 ident: pmed.1004011.ref013 publication-title: First WHO International Standard for SARS-CoV-2 RNA. – year: 2021 ident: pmed.1004011.ref232 article-title: SARS-CoV-2 Antigen Tests Predict Infectivity Based on Viral Culture: Comparison of Antigen, PCR Viral Load, and Viral Culture Testing on a Large Sample Cohort. publication-title: medRxiv – year: 2021 ident: pmed.1004011.ref168 article-title: Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community publication-title: Clin Microbiol Infect – volume: 93 start-page: 5650 issue: 9 year: 2021 ident: pmed.1004011.ref142 article-title: Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis publication-title: J Med Virol doi: 10.1002/jmv.27089 – volume: 107 start-page: 215 year: 2021 ident: pmed.1004011.ref040 article-title: Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.04.072 – start-page: 1 year: 2021 ident: pmed.1004011.ref137 article-title: Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern publication-title: Med Microbiol Immunol – volume: 153 start-page: 126 issue: 1 year: 2020 ident: pmed.1004011.ref075 article-title: Rapid chromatographic immunoassay-based evaluation of COVID-19: A cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India publication-title: Indian J Med Res – volume: 42 start-page: 100899 year: 2021 ident: pmed.1004011.ref045 article-title: The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. publication-title: New Microbes New Infect. doi: 10.1016/j.nmni.2021.100899 – volume: 133 start-page: 104659 year: 2020 ident: pmed.1004011.ref115 article-title: Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104659 – volume: 16 start-page: e0257817 issue: 9 year: 2021 ident: pmed.1004011.ref076 article-title: An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients. publication-title: PLoS ONE doi: 10.1371/journal.pone.0257817 – volume: 155 start-page: 529 issue: 8 year: 2011 ident: pmed.1004011.ref014 article-title: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies publication-title: Ann Intern Med doi: 10.7326/0003-4819-155-8-201110180-00009 – ident: pmed.1004011.ref201 – volume: 11 start-page: 995 issue: 6 year: 2021 ident: pmed.1004011.ref175 article-title: Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19. publication-title: Diagnostics doi: 10.3390/diagnostics11060995 – volume: 106 start-page: 8 year: 2021 ident: pmed.1004011.ref038 article-title: Analytical performances of the point-of-care SIENNA COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France. publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.03.051 – volume: 11 issue: 7 year: 2021 ident: pmed.1004011.ref121 article-title: SARS-CoV-2 Antigen Detection to Expand Testing Capacity for COVID-19: Results from a Hospital Emergency Department Testing Site. publication-title: Diagnostics doi: 10.3390/diagnostics11071211 – volume: 21 start-page: 1067 issue: 8 year: 2021 ident: pmed.1004011.ref189 article-title: SARS-CoV-2 rapid antigen detection tests publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00249-8 – year: 2021 ident: pmed.1004011.ref133 article-title: Field performance of NowCheck rapid antigen test for SARS-CoV-2 in Kisumu County, western Kenya. publication-title: medRxiv – start-page: 1 year: 2021 ident: pmed.1004011.ref167 article-title: Usefulness of rapid antigen testing for SARS-CoV-2 screening of healthcare workers: a pilot study. publication-title: Clin Exp Med. – volume: 21 start-page: 798 issue: 1 year: 2021 ident: pmed.1004011.ref090 article-title: Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests. publication-title: BMC Infect Dis doi: 10.1186/s12879-021-06524-7 – start-page: 1 year: 2021 ident: pmed.1004011.ref095 article-title: Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study publication-title: Eur J Clin Microbiol Infect Dis – volume: 18 start-page: 36 issue: 2 year: 2020 ident: pmed.1004011.ref165 article-title: Sensitivity and specificity of lateral flow antigen test kits for covid-19 in asymptomatic population of quarantine centre of province 3. publication-title: Kathmandu Univ Med J doi: 10.3126/kumj.v18i2.32942 – year: 2020 ident: pmed.1004011.ref059 article-title: The sensitivity of SARS-CoV-2 antigen tests in the view of large-scale testing. medRxiv – volume: 9 start-page: 647274 year: 2021 ident: pmed.1004011.ref089 article-title: Diagnostic Accuracy of SARS-CoV-2 Antigen Detection Test in Children: A Real-Life Study. publication-title: Front Pediatr. doi: 10.3389/fped.2021.647274 – volume: 1 start-page: 100013 issue: 1–2 year: 2021 ident: pmed.1004011.ref026 article-title: Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa. publication-title: J Clin Virol Plus doi: 10.1016/j.jcvp.2021.100013 – volume: 140 start-page: 104846 year: 2021 ident: pmed.1004011.ref131 article-title: SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus. publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104846 – volume: 132 start-page: 104654 year: 2020 ident: pmed.1004011.ref048 article-title: Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2. publication-title: J Clin Virol. doi: 10.1016/j.jcv.2020.104654 – volume: 27 issue: 10 year: 2021 ident: pmed.1004011.ref179 article-title: Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students publication-title: Emerg Infect Dis doi: 10.3201/eid2710.210080 – volume: 53 start-page: 661 issue: 9 year: 2021 ident: pmed.1004011.ref081 article-title: Covid-19 antigen testing: better than we know? publication-title: A test accuracy study Infectious Diseases. – volume: 107 start-page: 201 year: 2021 ident: pmed.1004011.ref140 article-title: Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.04.087 – year: 2021 ident: pmed.1004011.ref120 article-title: Performance of antigenic detection of SARS-CoV-2 in nasopharyngeal samples. publication-title: medRxiv – start-page: 1 year: 2021 ident: pmed.1004011.ref166 article-title: Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions. publication-title: Infect Control Hosp Epidemiol. doi: 10.1017/ice.2021.281 – start-page: jcm0247921 year: 2021 ident: pmed.1004011.ref217 article-title: Assessment of the analytical sensitivity of ten lateral flow devices against the SARS-CoV-2 omicron variant publication-title: J Clin Microbiol – ident: pmed.1004011.ref207 – volume: 141 start-page: 104878 year: 2021 ident: pmed.1004011.ref068 article-title: Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study. publication-title: J Clin Virol. doi: 10.1016/j.jcv.2021.104878 – volume: 27 start-page: 1493 issue: 10 year: 2021 ident: pmed.1004011.ref109 article-title: The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2. publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.07.006 – year: 2020 ident: pmed.1004011.ref172 article-title: SARS-CoV-2 qRT-PCR Ct value distribution in Japan and possible utility of rapid antigen testing kit. publication-title: medRxiv – volume: 59 start-page: e02727 issue: 2 year: 2020 ident: pmed.1004011.ref033 article-title: Comparison of Quidel Sofia SARS FIA Test to Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients publication-title: J Clin Microbiol – volume: 8 start-page: 322 issue: 3 year: 2021 ident: pmed.1004011.ref153 article-title: Clinical assessment of the Roche SARS-CoV-2 rapid antigen test. publication-title: Diagnosis doi: 10.1515/dx-2020-0154 – year: 2021 ident: pmed.1004011.ref225 article-title: Saliva swabs are the preferred sample for Omicron detection. publication-title: medRxiv – volume: 27 start-page: 890 issue: 6 year: 2021 ident: pmed.1004011.ref173 article-title: The evaluation of a newly developed antigen test (QuickNavi-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan. publication-title: J Infect Chemother doi: 10.1016/j.jiac.2021.02.029 |
| SSID | ssj0029090 |
| Score | 2.581082 |
| SecondaryResourceType | review_article |
| Snippet | Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is... Background Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2... Lukas Brümmer and co-workers report an updated systematic review and meta-analysis on the accuracy of antigen-based rapid diagnostic tests for SARS-CoV-2... BackgroundComprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2... Background Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e1004011 |
| SubjectTerms | Accuracy Age groups Antigens Asymptomatic Biology and Life Sciences Coronaviruses COVID-19 Disease transmission Estimates Immune system Medicine and Health Sciences Meta-analysis Nose Patients Physical Sciences Point of care testing Polymerase chain reaction Public health Regression analysis Research and Analysis Methods Reverse transcription Sensitivity analysis Severe acute respiratory syndrome coronavirus 2 Standardization Systematic review Testing Web sites Websites |
| SummonAdditionalLinks | – databaseName: DOAJ dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQCiEuiHcDBQxCcDKNnawdc1sqKjiwoC5UvUWOHW9XKkm0DyT4S_xJZhJvaNBK7YE9rTJfImXG9sw4428IeSkLwZ3RCRs761kqZckM5NhMJd5lGoxejG3bbEJNp9npqf5yodUX1oR19MCd4g6k1QIGmnBK2NSPS6N8puO44MKit2wTn1jpbTIVUi0dt7sryD_GuFAqHJpLFD8INnrTgLfBGgFIMPjAKbXc_f0KPWrO69Wu8PPfKsoLbunoNrkV4kk66d7jDrlWVnfJjU_hi_k98nti7WZp7E9ae7o0zcLRpl5Ua1Z7hlVfFDSLhJwM3Zmjrqu8Q-5mCuEsnU2OZ-ywPmHiLZ1UdNPgBoGjf_mfaXf2BR7j6PdybZgJLCcUd3i7S8ty3lXbVrSV_gJ3SRehOwr-D01_7pNvR--_Hn5goUEDs0qmazCtEV4XmTRSaAORT8mLtAQLx-ABvLTexco7C1FcWigVm0wqm0DIo2OnbBG75AEZVXVV7hEq0wJ-CSwHgqcmKyEs9Rk3EL5Yx7U1EUm2FsptYC_HJhrneftJTkEW0yk8R7vmwa4RYf1dTcfecQn-HRq_xyL3dnsBRmQeRmR-2YiMyDMcOnl3kLVfQfKJipEtMc3iiLxoEci_UWGBz9xsVqv84-eTK4Bm06uAjgeg1wHka9CZNeHkBWgeyb8GyFcD5LyjPt8F3B8AYU2yA_EeTputjle5kEohdxzHO7dTabf4eS_Gh2IJYFXWmxbDhczAaUTkYTfzejslkAWoRI0jogZzcmDIoaRanLVk6pqDx9Li0f-w_GNyU-DpmBgLR_fJaL3clE_IdftjvVgtn7Yr1B9SppUE priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELagIISEeCyPLSxgEIKTWcdJ45gLKitWcKCgXVj1Fjl2UiotSUhaJPhL_ElmYrclqIKV6KmKv0SJZzwztsffEPIkzkRgtQrZyJqCRXGcMw1zbCbDwiYKhJ6NTFdsQk4myXSqPvgFt9anVa5sYmeobWVwjXxfxFIi-1TAX9ZfGVaNwt1VX0LjPLmAZbNRz-V0M-FSvFtjQRYyFggp_dG5UAb7XlLPa_A5mCkA04yg55o6Bv-1nR7Up1W7LQj9M5fyN-d0eO1_P-s6uerDUjp2enSDnMvLHXLpnd943yFX3PIedaeWbpKfY2OWjTbfaVXQRtdzS-tqXi5YVTBMJqMgMOT5ZOglLbUuoQ8poSlEyfR4fHTMDqoTJl7QcUmXNa47WLqhlabuSA08xtIv-UIz7clTKC4cu0tNPnNJvCXtWn-AF6ZzX3QF__taQrfIp8PXHw_eMF_3gRnoiwVojBaFypJYx0JpCKjyIItyUBwOjqWITWG5LKyB4DDKpOQ6iaUJIZJS3EqTcRveJoOyKvNdQuMog18IVkYEkU5yiHaLJNAQFRkbKKOHJFyJPDWeFB1rc5ym3U6fhMmRE0CKipJ6RRkStr6rdqQg_8C_Qm1aY5HSu7tQNbPUW4g0NkoAWlgpTFSMcg1vqjjPAmEwLISHPERdTN352LVhSseSIwljlPAhedwhkNajxLyhmV62bfr2_ckZQMeTs4COeqBnHlRU0GdG-wMd0PPIKdZDPu0hZ45RfRtwrwcEU2d6zbs4Dld93Kab0QN3rsbX9uZH62Z8KGYWlnm17DCBiBPwRUNyxw3ltZxCmFzIUI6GRPYGeU-Q_ZZy_rnjaFdgjrgSd__-WvfIZYHHaThmmu6RwaJZ5vfJRfNtMW-bB50x-wW9BKkY priority: 102 providerName: ProQuest |
| Title | Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35617375 https://www.proquest.com/docview/2677645410 https://www.proquest.com/docview/2671268053 https://pubmed.ncbi.nlm.nih.gov/PMC9187092 https://doaj.org/article/6c920402d72c4f5ea7f8900b12c06631 http://dx.doi.org/10.1371/journal.pmed.1004011 |
| Volume | 19 |
| WOSCitedRecordID | wos000944355600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: 7X7 dateStart: 20041001 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: BENPR dateStart: 20041001 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: PIMPY dateStart: 20041001 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: FPL dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLagQwgJcRmXFUYxCMGTIXFSO-atm1YxiZWqhak8RY6dlEojqXpBgr_En-ScxM3I1InRh6iyP1uWj-1zjn38mZBXIuG-1SpgXWsyFgqRMg0-NpNBZiMFQk-6pnxsQg4G0WSihueO4oUT_ED671yfvp2DdsAzfXAIwNvZ4YEQ6Gz1hx9rB0t5ynPX4y4r2VA_JUt_vRa35mfFcpuheTFe8i8F1L_7v02_R-44U5P2qrFxn1xL811y88Qdpu-S29WWHa1uIj0gv3vGrBfa_KRFRhd6PrN0XszyFSsyhgFiFISA3J0MNZ-ltgrSQ5pnCpYvHfdGY3ZYnDL-nvZyup7jXoKl51TRtLomA9VY-j1daaYdIQrFzeAqaZFOq8DcnJa5v0Cz0pl7SAX_u_eBHpIv_aPPhx-Ye8uBGSnCFYwCzTOVREILrjQYSamfhCkMBg-URSZMZj2ZWQMGX5hI6elISBOAdaQ8K03i2eARaeVFnu4RKsIEfgGsHNwPdZSCBZtFvgZLx1hfGd0mwUbEsXFE5_jexllcnt5JcHgqAcQol9jJpU1YXWpeEX38A3-Ao6fGIk13mQADIHazPhZGcUBzK7kJs26qoaXK8xKfGzT1oJLnOPbi6s5rvdjEPekhsWIYeW3yskQgVUeOsUBTvV4u4-NPp1cAjQdXAY0aoDcOlBXQZ0a7SxrQ88gT1kC-biCnFUv6NuB-AwjLl2lk7-G82_TxMuZCSqSZ87HkZi5uz35RZ2OlGC2Yp8W6xPhcRKBf2uRxNXVrOQXgMMhAdttENiZ1Q5DNnHz2reRdVz4oN8WfXN7ip-QWx-sxHkaO7pPWarFOn5Eb5sdqtlx0yHU5keU36pCdg6PBcNQp94A65TIGacPjk-HXPwdsm3E |
| linkProvider | Public Library of Science |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGQYCE-BgfKwxmEB9PZomTxgkSQmUwrdpW0DqmvgXHTkqlkYR-gMa_hMTfyF3stgRVsJc90Kcq_sWy7POdz7n7HSGPg4S7WkYea2mVMT8IUibBx2bCy3QYwaInLVUVmxDdbtjvR-9XyM9ZLgyGVc50YqWodaHwjnyTB0Ig-5TrvCq_MKwahV9XZyU0jFjspiffwGUbv-y8gfV9wvn228OtHWarCjAFHUxgPJJnURIGMuCRBHOduomfwrAcUFtZoDLtiEwrOHr4iRCODAOhPLDTkaOFShztQb_nyHnQ4wKdPdFfOHiRU93pIOsZc7kQNlXPE-6mlYznJdg4jEwAt8atmcKqYsDcLjTK42K87ND7Z-zmb8Zw-9r_No3XyVV77KZts09ukJU0XyUX921gwSq5Yq4vqcnKukl-tJWajqQ6oUVGR7IcaloWw3zCioxhsBwFgUQeU4anAE21CVhEymsKXgDttQ96bKs4YvwFbed0WuK9iqYL2mxqUoagG00_pxPJpCWHoXgxbh6N0oEJUs5p1fodThl0aIvK4H9bK-kW-XAmU3ebNPIiT9cIDfwEfh5oUe76MkxBJrPQlXDqU9qNlGwSbyZisbKk71h75DiuvmQKcP7MAsQomLEVzCZh87dKQ3ryD_xrlN45FinLqwfFaBBbDRgHKuKA5lpw5WetVMJII8dJXK7w2AudbKDsxyb_d65447ZwkGTSD50meVQhkLYkx7iogZyOx3Hn3dEpQL3uaUAHNdAzC8oKmDMlbcIKzDxyptWQT2vIgWGMXwZcrwFBlata8xru-9kcj-PFboU3Z_t5efPDeTN2ipGTeVpMK4zLgxBsbZPcMapjvk4eOE_CE60mETWlUlvIeks-_FRx0EcuGPqI3_37sDbIpZ3D_b14r9PdvUcuc0wdcjCqdp00JqNpep9cUF8nw_HoQaVIKfl41irnF71FBhE |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtQwELXKFlVIiEu5dKFQg6A8mSZONk6QEFpaKlaly6qFqjwFx06WlUoS9gIqv8Qf8HXMxN6UoAr60gf2aRVPLMseH884M2cIeRQk3NUy8lhHq4z5QZAyCT42E16mwwgWPemoqtiE6PfDw8NosEB-znNhMKxyjokVUOtC4R35Bg-EQPYp19nIbFjEYGv7RfmFYQUp_NI6L6dhVGQnPf4G7tvkeW8L1vox59uv3m2-ZrbCAFPQ2RTGJnkWJWEgAx5JOLpTN_FTGKIDEJYFKtOOyLQCM8RPhHBkGAjlwZkdOVqoxNEe9HuBLIJJ7vMWWRz0dgcfancvcqobHuRAYy4XwibuecLdsHrytIQTD-MUwMlxGwdjVT-gPiVa5VExOc0E_jOS87ejcfvq_zyp18gVa5DTrtlB18lCmi-TpV0bcrBMLpuLTWrytW6QH12lZmOpjmmR0bEsR5qWxSifsiJjGEZHQVWR4ZShfaCpNqGMSIZNwT-g-929fbZZHDD-jHZzOivxxkXTE0JtapKJoBtNP6dTyaSljaF4ZW4ejdOhCV_OadX6HewPOrLlZvC_raJ0k7w_l6m7RVp5kacrhAZ-Aj8P8JW7vgxTsPOz0JVgDyrtRkq2iTdXt1hZOnisSnIUV984BbiFZgFiVNLYKmmbsPqt0tCh_EP-JWpyLYtk5tWDYjyMLTbGgYo4SHMtuPKzTiphpJHjJC5XaBBDJ2u4D2KTGVxDctwVDtJP-qHTJg8rCSQ0yVGLh3I2mcS9twdnENrvn0VoryH0xAplBcyZkjaVBWYe2dQakusNyaHhkj9NcLUhCCCvGs0riAHzOZ7EJzsX3pzv7dObH9TN2CnGVOZpMatkXB6EcAq3yW0DI_U6eeBWCU902kQ0AKaxkM2WfPSpYqePXDABIn7n78NaI0uANPGbXn_nLrnEMafIwXDbVdKajmfpPXJRfZ2OJuP7FlUp-XjemPMLI2QQYA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accuracy+of+rapid+point-of-care+antigen-based+diagnostics+for+SARS-CoV-2%3A+An+updated+systematic+review+and+meta-analysis+with+meta-regression+analyzing+influencing+factors&rft.jtitle=PLoS+medicine&rft.au=Br%C3%BCmmer%2C+Lukas+E&rft.au=Katzenschlager%2C+Stephan&rft.au=McGrath%2C+Sean&rft.au=Schmitz%2C+Stephani&rft.date=2022-05-26&rft.issn=1549-1676&rft.eissn=1549-1676&rft.volume=19&rft.issue=5&rft.spage=e1004011&rft_id=info:doi/10.1371%2Fjournal.pmed.1004011&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |